From Bench to Bedside: Clinical Implications of a 4-Micron Surface-Modulated Immune Response in the Era of Breast Tissue Preservation.

Authors

M Bradley Calobrace, Brian M Kinney, Joshua C Doloff, Omid Veiseh, Alicia Billington, Steven Teitelbaum, Alexandre Mendonça Munhoz, Manuel Chacón-Quiros

Published in

Aesthetic surgery journal. Volume 46. Issue Supplement_2. Pages S96-S108. Aug 11, 2026.

Abstract

Breast implant surface topography plays a critical role in modulating host immune responses and long-term clinical outcomes. Although traditional classifications dichotomize implant surfaces as smooth or textured, emerging evidence demonstrates that specific architectural parameters differentially regulate macrophage polarization, T cell recruitment, and fibrotic capsule formation. This narrative review synthesizes preclinical, translational, and clinical evidence evaluating immune modulation associated with a specific 4 µm surface architecture and discusses its implications for capsular contracture, chronic inflammation, biointegration, and the corresponding consequences for conservative surgical techniques. Across animal models, capsule histology, proteomic analyses, and gene expression studies, this specific 4 µm surface consistently demonstrates reduced proinflammatory macrophage infiltration, enhanced FoxP3 + regulatory T cell recruitment, and decreased profibrotic signaling with thinner yet elastic structured capsules compared with both conventional smooth and high roughness surfaces, favoring immune regulation rather than chronic inflammation. Capsule behavior is governed not by thickness alone but by structural organization, elasticity, and immune profile. Clinically, these findings translate into low rates of capsular contracture without increased risks of implant instability, when appropriately managed. Collectively, these converging data support a broader conceptual framework in which foreign body response is a biologically modifiable process. Modulating this response through surface topography enables the development of an optimized implant-tissue interface that promotes physiologic healing, minimizes adverse outcomes, and supports natural breast biomechanics. Within this framework, coupling this specific architecture with breast tissue-preserving techniques, this biologic profile provides a foundation for stable, low-inflammatory implant integration without reliance on complex maneuvers, additional structural support or excessive fibrotic adhesion. Level of Evidence: 5 (Therapeutic)  For image description, please refer to the figure legend and surrounding text.

PMID:
42579318
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.